{"nctId":"NCT03549520","briefTitle":"CEUS Evaluation of Hypoxic Ischemic Injury","startDateStruct":{"date":"2020-12-01","type":"ACTUAL"},"conditions":["Hypoxic-Ischemic Encephalopathy","Brain Ischemia Hypoxia"],"count":1,"armGroups":[{"label":"Contrast-enhanced Ultrasonography","type":"EXPERIMENTAL","interventionNames":["Drug: Sulfur hexafluoride lipid-type A microspheres"]}],"interventions":[{"name":"Sulfur hexafluoride lipid-type A microspheres","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Males and females aged 1.5 years or younger with open fontanelles and known or suspected hypoxic ischemic injury.\n2. Post menstrual age of 34 weeks or older\n3. Patient in the Children's Hospital of Philadelphia (CHOP) Neonatal Intensive Care Unit (NICU) or Pediatric Intensive Care Unit (PICU)\n4. Parental permission\n\nExclusion Criteria:\n\n1. Medical history of Lumason hypersensitivity\n2. Hemodynamic instability as defined by rapid escalation of cardiopulmonary support in the past 12-24 hours, as defined by the clinical care team including â‰¥ 1 intensive care physician not part of the study team\n3. Pulmonary insufficiency as defined by fraction of inspired oxygen (FiO2) requirements of \\> 40% and/or subjects with pulmonary hypertension requiring nitric oxide","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Minute","maximumAge":"18 Months","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Detection of Brain Perfusion Abnormalities Using Contrast-enhanced Ultrasound","description":"Comparison of brain perfusion between normal subjects (those with suspected or at risk of HII but turn out to be normal on imaging and clinical evaluation) versus HII patients","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Completed Brain CEUS Exams, Categorized by Diagnostic-Quality Scoring System","description":"Scoring system of non-diagnostic (1), moderate artifacts degrading diagnostic quality (2), mild artifacts without degradation of diagnostic quality (3), and diagnostic (4).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":1},"commonTop":[]}}}